Why is Medical Properties Trust stock sliding today?
Medical Properties Trust (MPT) stock fell 8.8% to $2.20 after RBC downgraded it to Underperform, citing tenant vulnerabilities and liquidity issues. MPT missed Q3 2026 revenue estimates at $250.14M and reported lower Normalized FFO at $0.11 per share. RBC cut its price target to $2.00, reflecting lower earnings expectations. The decline was driven by company-specific news, not broader market trends.
How this was made
The 30-second read
Why it matters
The downgrade and earnings miss combine to create a strong sell signal, pushing the stock toward its 52‑week low.
Market read
MPT's sharp decline reflects company‑specific risk and may influence sentiment toward other healthcare REITs.
What to watch
Potential upside from any upcoming tenant restructuring or new lease agreements not yet disclosed.
Background
Medical Properties Trust (MPT) is a healthcare-focused REIT that recently reported Q3 2026 earnings below consensus, with tenant HSA missing rent. RBC's downgrade follows the earnings release.
Ticker impact
RBC downgraded Medical Properties Trust to Underperform and cut the price target, triggering an 8.8% slide after the Q3 earnings miss.
likely continued pressure as investors price in lower earnings outlook and liquidity concerns
The downgrade is fresh, the price target cut is sizable, and the stock already fell 8.8% on the news, indicating strong negative sentiment.
Market effects
Healthcare REITs may face heightened scrutiny as tenant liquidity issues surface.
U.S. REIT sector could see modest pullback amid broader market weakness.
Limited to U.S. equity markets; no direct global macro impact.
Counterpoint
If the tenant issues are temporary, the stock may be oversold and could rebound on a later earnings beat.
Key entities
- analystRBC Capital Markets
Downgraded MPT to Underperform and cut price target to $2.00.
- tenantHSA
Failed to remit September rent, contributing to lower FFO.


